BAYESIAN METHODS IN COST-EFFECTIVENESS STUDIES: OBJECTIVITY, COMPUTATION AND OTHER RELEVANT ASPECTS

被引:3
|
作者
Armero, C. [2 ]
Garcia-Donato, G. [1 ]
Lopez-Quilez, A. [2 ]
机构
[1] Univ Castilla La Mancha, Dept Anal Econ & Finanzas, Albacete, Spain
[2] Univ Valencia, Dept Estadist & IO, Valencia, Spain
关键词
cost-effectiveness studies; objective Bayesian methods; probabilistic sensitivity analysis; GASTROESOPHAGEAL REFLUX DISEASE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MEDICAL DECISION-MAKING; RHEUMATOID-ARTHRITIS; EFFECTIVENESS MODELS; EROSIVE ESOPHAGITIS; PRIOR DISTRIBUTIONS; ECONOMIC-EVALUATION; GOLDSTEIN; ARTICLES;
D O I
10.1002/hec.1496
中图分类号
F [经济];
学科分类号
02 ;
摘要
In a probabilistic sensitivity analysis (PSA) of a cost-effectiveness (CE) study, the unknown parameters are considered as random variables. A crucial question is what probabilistic distribution is suitable for synthesizing the available information (mainly data from clinical trials) about these parameters. In this context, the important role of Bayesian methodology has been recognized, where the parameters are of a random nature. We explore, in the context of CE analyses, how formal objective Bayesian methods can be implemented. We fully illustrate the methodology using two CE problems that frequently appear in the CE literature. The results are compared with those obtained with other popular approaches to PSA. We find that the discrepancies can be quite marked. specially when the number of patients enrolled in the simulated cohort under study is large. Finally, we describe in detail the numerical methods that need to be used to obtain the results. Copyright (C) 2009 John Wiley & Sons. Ltd.
引用
收藏
页码:629 / 643
页数:15
相关论文
共 50 条
  • [1] Formal objective Bayesian methods in cost-effectiveness studies
    Armero, C.
    Garcia-Donato, G.
    Lopez-Quilez, A.
    VALUE IN HEALTH, 2007, 10 (06) : A451 - A451
  • [2] Bayesian cost-effectiveness analysis: Illustration of methods.
    Fryback, DG
    Chinnis, JO
    Uvila, J
    MEDICAL DECISION MAKING, 1998, 18 (04) : 484 - 484
  • [3] Bayesian methods for evidence synthesis in cost-effectiveness analysis
    A. E. Ades
    Mark Sculpher
    Alex Sutton
    Keith Abrams
    Nicola Cooper
    Nicky Welton
    Guobing Lu
    PharmacoEconomics, 2006, 24 : 1 - 19
  • [4] Bayesian methods for evidence synthesis in cost-effectiveness analysis
    Ades, AE
    Sculpher, M
    Sutton, A
    Abrams, K
    Cooper, N
    Welton, N
    Lu, GB
    PHARMACOECONOMICS, 2006, 24 (01) : 1 - 19
  • [5] Bayesian cost-effectiveness analysis with two measures of effectiveness:: the cost-effectiveness acceptability plane
    Negrín, MA
    Vázquez-Polo, FJ
    HEALTH ECONOMICS, 2006, 15 (04) : 363 - 372
  • [6] How relevant is cost-effectiveness anyway?
    Caro, J. Jaime
    EUROPEAN HEART JOURNAL, 2013, 34 (04) : 245 - 246
  • [7] Methods for Handling Unobserved Covariates in a Bayesian Update of a Cost-effectiveness Model
    Thorpe, Benjamin
    Carroll, Orlagh
    Sharples, Linda
    MEDICAL DECISION MAKING, 2018, 38 (02) : 150 - 162
  • [8] COST-EFFECTIVENESS STUDIES
    不详
    BRITISH MEDICAL JOURNAL, 1978, 2 (6141): : 848 - 849
  • [9] COST-EFFECTIVENESS STUDIES
    DAVIES, T
    SMITH, P
    BRITISH MEDICAL JOURNAL, 1978, 2 (6145): : 1160 - 1160
  • [10] COST-EFFECTIVENESS STUDIES
    WARD, P
    BRITISH MEDICAL JOURNAL, 1978, 2 (6146): : 1231 - 1231